Cargando…

Pharmacokinetics of Antituberculosis Drugs in Plasma and Cerebrospinal Fluid in a Patient with Pre-Extensive Drug Resistant Tuberculosis Meningitis

Drug-resistant tuberculous meningitis (TBM) is the most devastating and critical form of extrapulmonary tuberculosis. Here, we present a case of a 45-year-old male with pre-extensive drug-resistant tuberculosis meningitis (pre-XDR-TBM). He underwent emergency surgery for the long-tunneled external v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zhilin, Liao, Weiming, Chen, Qifu, Li, Hui, Ye, Meiling, Zou, Jin, Deng, Guofang, Zhang, Peize
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041991/ https://www.ncbi.nlm.nih.gov/pubmed/36992966 http://dx.doi.org/10.2147/IDR.S401281

Ejemplares similares

Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis
por: Panjasawatwong, Navarat, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis
por: Ding, Junjie, et al.
Publicado: (2020)

Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
por: Hernandez-Cardenas, CH, et al.
Publicado: (2014)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
por: van der Laan, Louvina E., et al.
Publicado: (2021)

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis
por: Maranchick, Nicole F., et al.
Publicado: (2022)

Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi
por: van Oosterhout, J. J., et al.
Publicado: (2015)

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis
por: Verscheijden, Laurens F. M., et al.
Publicado: (2019)

Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study
por: Senbayrak, Seniha, et al.
Publicado: (2015)

Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen
por: Heemskerk, A Dorothee, et al.
Publicado: (2017)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug–Drug Interactions With Antiretroviral and Antituberculosis Treatment
por: Francis, Jose, et al.
Publicado: (2021)

Antituberculosis drug-induced hepatotoxicity in children
por: Donald, Peter R
Publicado: (2011)

Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs
por: Wu, Yuqing, et al.
Publicado: (2021)

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
por: Salinger, David H., et al.
Publicado: (2019)

Mycobacterium tuberculosisβ-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
por: Aspatwar, Ashok, et al.
Publicado: (2019)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
por: Kalo, Deepika, et al.
Publicado: (2015)

Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine
por: Bohn, Jan-Paul, et al.
Publicado: (2019)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis
por: Schutz, Charlotte, et al.
Publicado: (2020)

Extensive Radiological Manifestation in Patients with Diabetes and Pulmonary Tuberculosis: A Cross-Sectional Study
por: Zhan, Senlin, et al.
Publicado: (2022)

Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
por: Micheletti, Vania Celina Dezoti, et al.
Publicado: (2014)

Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis
por: Han, Yi-Ran, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis Meningitis
por: Nuwagira, Edwin, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery
por: Lu, Cheng, et al.
Publicado: (2016)

Antituberculosis Drug-Induced Fixed Drug Eruption: A Case Report
por: Vaghela, Jitendra H., et al.
Publicado: (2018)

Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai
por: Chen, Yong, et al.
Publicado: (2016)

Risk factors associated with adverse reactions to antituberculosis drugs
por: Resende, Laíse Soares Oliveira, et al.
Publicado: (2015)

Seizures following Intoxication with a Common Antituberculosis Drug
por: Lahlou, Adnane, et al.
Publicado: (2019)

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
por: Bespyatykh, Julia, et al.
Publicado: (2020)

Evaluation of cerebrospinal fluid and blood parameters finding in early diagnosis and drug therapy of suspected bacterial meningitis in neonates
por: Li, Huixian, et al.
Publicado: (2020)

Estimation of cerebrospinal fluid cortisol level in tuberculous meningitis
por: Mahale, Rohan R., et al.
Publicado: (2015)

Estimation of cerebrospinal fluid cortisol level in tuberculous meningitis
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2016)

Identification of Cerebrospinal Fluid Metabolites as Biomarkers for Enterovirus Meningitis
por: Ratuszny, Dominica, et al.
Publicado: (2019)

Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis
por: Gómez-Baena, Guadalupe, et al.
Publicado: (2017)

Metagenomic sequencing of cerebrospinal fluid from children with meningitis
por: Grose, Charles
Publicado: (2022)

Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis
por: Pouplin, Thomas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gghmmc5a85cel1bl72i90red54